Opgen Inc (NASDAQ:OPGN) traded with an addition of $0.19 to close at $0.39on Friday, an upside of 92.54 percent. An average of 16,326,538 shares of common stock have been traded in the last five days. There was a gain of $0.1710 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 4,277,555 shares traded, while the 50-day average volume stands at 2,065,922.
OPGN stock has increased by 121.14% in the last month. The company shares reached their 1-month lowest point of $0.1650 on 08/30/23. With the stock rallying to its 52-week high on 01/04/23, shares of the company touched a low of $0.17 and a high of $9.05 in 52 weeks. It has reached a new high 2 times so far this year and lost -86.28% or -$2.4200 in price. In spite of this, the price is down -95.73% from the 52-week high.
Valuation Metrics
Opgen Inc (OPGN) has a trailing price-to-earnings (P/E) ratio of N/A for the broader industry. The stock’s beta is -0.18. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.22, the price-to-book (PB) ratio at 0.39.
Financial Health
The quick ratio of Opgen Inc for the three months ended June 30 was 0.44, and the current ratio was 0.58, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.44 and a total debt to equity ratio of 1.85 for the quarter ending June 30. Its gross profit as reported stood at -$0.82 million compared to revenue of $2.61 million.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$5.83 million in the quarter, while revenues of -$5.74 million were shrunk -0.17%. The analyst consensus anticipated Opgen Inc’s latest quarter earnings to come in at -$0.71 per share, but it turned out to be -$0.93, a -31.00% surprise. For the quarter, EBITDA amounted to -$4.79 million. Shareholders own equity worth $8.9 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Opgen Inc (OPGN) price momentum. RSI 9-day as of the close on 28 September was 81.87%, suggesting the stock is Overbought, with historical volatility in this time frame at 355.71%.
As of today, OPGN’s price is $0.2505 +74.67% or $0.1710 from its 5-day moving average. OPGN is currently trading +110.53% higher than its 20-day SMA and -45.95% lower than its 100-day SMA. However, the stock’s current price level is -35.59% below the SMA50 and -84.00% below the SMA200.
The stochastic %K and %D were 31.57% and 32.87%, respectively, and the average true range (ATR) was 0.0594. With the 14-day stochastic at 58.35% and the average true range at 0.0507, the RSI (14) stands at 71.96%. The stock has reached 0.0250 on the 9-day MACD Oscillator while the 14-day reading was at 0.0336.
Analyst Ratings
Alliance Global Partners launched coverage on Opgen Inc (NASDAQ: OPGN) in its analyst report released on March 01, 2019. The firm assigned the stock a Buy rating.
